At a glance
- Originator Kyowa Hakko
- Class Antineoplastics; Pyrroles
- Mechanism of Action Alkylating agents; DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 13 Oct 2006 Discontinued - Preclinical for Cancer in Japan (unspecified route)
- 17 Aug 2001 No-Development-Reported for Cancer in Japan (Unknown route)
- 10 May 1995 Preclinical development for Cancer in Japan (Unknown route)